GIS vs ORMP
General Mills Inc (GIS) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported GIS revenue for 2025-05-25 was $4.56B. Net income was $2.32B. Revenue was down 5.9% from 2025-02-23 to 2025-05-25. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
GIS currently screens at market cap $17.80B and trailing P/E 8.2. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the GIS and ORMP stock pages for the full models.
Not investment advice.